Table 3 Causal effects of COVID-19 on longevity in univariate MR study
From: COVID-19 infection and longevity: an observational and mendelian randomization study
Exposure | Method | No. SNP | OR (95%CI) | P value |
|---|---|---|---|---|
COVID-19 | IVW | 14 | 0.78 (0.55-)1.11 | 0.17 |
|  | Weighted median | 14 | 0.71 (0.45–1.13) | 0.15 |
|  | GSMR | 29 | 0.78 (0.57–1.06) | 0.12 |
|  | MR Egger | 14 | 0.94 (0.49–1.79) | 0.85 |
very severe COVID-19 | IVW | 28 | 0.94 (0.88–1.01) | 0.077 |
|  | Weighted median | 28 | 0.94 (0.86–1.02) | 0.14 |
|  | GSMR | 49 | 0.91 (0.84–0.98) | 0.015 |
|  | MR Egger | 28 | 0.92 (0.82–1.04) | 0.20 |
hospitalized COVID-19 | IVW | 32 | 0.86 (0.74-1.00) | 0.055 |
|  | Weighted median | 32 | 0.88 (0.73–1.07) | 0.21 |
|  | GSMR | 46 | 0.91 (0.81–1.02) | 0.11 |
|  | MR Egger | 32 | 0.89 (0.67–1.18) | 0.43 |